Literature DB >> 9784323

Analysis of allelic imbalance on chromosome 17p13 in stage I and stage II epithelial ovarian cancers.

D W Wiper1, K M Zanotti, A W Kennedy, J L Belinson, G Casey.   

Abstract

OBJECTIVES: To determine whether there is evidence for allelic imbalance (AI) on chromosome 17p13 in early-stage epithelial ovarian tumors.
METHODS: Studies of allelic imbalance were performed on 29 stage I or stage II epithelial ovarian cancers using 5 short tandem repeat polymorphic markers (STRPs) on chromosome 17p13 by polymerase chain reaction (PCR) amplification.
RESULTS: Sixteen of 29 (55%) tumors showed AI at one or more loci, including 7 of 29 (24%) tumors that showed distinct regions of AI. AI at p53 was present in only 9 of 25 (36%) informative tumors. A region of AI, defined by marker D17S654, close to candidate genes OVCA1 and OVCA2, was identified distal to p53 and occurred in 11 of 23 (48%) informative tumors. This region of AI also extended more distal to this locus, and included marker D17S695 where AI occurred in 11 of 26 (42%) informative tumors. Microsatellite instability was observed in 2 of 29 tumors.
CONCLUSIONS: This study supports the presence of at least one tumor suppressor gene on chromosome 17p13 distal to p53 that is involved in the early development of epithelial ovarian cancer. This study also suggests that the molecular analysis of early-stage epithelial ovarian cancers can provide important information on the genetic etiology of ovarian cancers. Copyright 1998 Academic Press.

Entities:  

Mesh:

Year:  1998        PMID: 9784323     DOI: 10.1006/gyno.1998.5110

Source DB:  PubMed          Journal:  Gynecol Oncol        ISSN: 0090-8258            Impact factor:   5.482


  4 in total

Review 1.  Miller-Dieker syndrome: analysis of a human contiguous gene syndrome in the mouse.

Authors:  Jessica Yingling; Kazuhito Toyo-Oka; Anthony Wynshaw-Boris
Journal:  Am J Hum Genet       Date:  2003-08-05       Impact factor: 11.025

2.  OVCA1 inhibits the proliferation of epithelial ovarian cancer cells by decreasing cyclin D1 and increasing p16.

Authors:  Fandou Kong; Rui Tong; Lingyu Jia; Wei Wei; Xiaoyan Miao; Xinyu Zhao; Wenping Sun; Guang Yang; Chunyan Zhao
Journal:  Mol Cell Biochem       Date:  2011-04-13       Impact factor: 3.396

3.  OVCA1 expression and its correlation with the expression levels of cyclin D1 and p16 in cervical cancer and intraepithelial neoplasia.

Authors:  Rui Tong; Qing Yang; Chunyan Wang; Fangfang Bi; Bing Jiang
Journal:  Oncol Lett       Date:  2017-03-13       Impact factor: 2.967

4.  Different behaviour of DVL1, DVL2, DVL3 in astrocytoma malignancy grades and their association to TCF1 and LEF1 upregulation.

Authors:  Anja Kafka; Mateja Bačić; Davor Tomas; Kamelija Žarković; Anja Bukovac; Niko Njirić; Goran Mrak; Željka Krsnik; Nives Pećina-Šlaus
Journal:  J Cell Mol Med       Date:  2018-11-23       Impact factor: 5.310

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.